Ascensia Diabetes Care India Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 15.00 Cr
as on 07-07-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 6.12%
(FY 2023)
- Profit 43.05%
(FY 2023)
- Ebitda -13.22%
(FY 2023)
- Net Worth 23.56%
(FY 2023)
- Total Assets 20.76%
(FY 2023)
About Ascensia Diabetes Care India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ketki Save, Albertraj Balraj, and Katharina Beygang serve as directors at the Company.
- CIN/LLPIN
U85191MH2015FTC269883
- Company No.
269883
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
05 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ascensia Diabetes Care India Private Limited offer?
Ascensia Diabetes Care India Private Limited offers a wide range of products and services, including Devices, Test Strips & Lancets.
Who are the key members and board of directors at Ascensia Diabetes Care India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketki Save  | Director | 05-Nov-2015 | Current |
| Albertraj Balraj | Director | 24-Aug-2018 | Current |
Katharina Beygang  | Director | 28-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Ascensia Diabetes Care India.
Ascensia Diabetes Care India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.12% increase. The company also saw a substantial improvement in profitability, with a 43.05% increase in profit. The company's net worth Soared by an impressive increase of 23.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ascensia Diabetes Care India?
In 2023, Ascensia Diabetes Care India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ascensia Diabetes Care India?
Ascensia Diabetes Care India has a workforce of 119 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ascensia Diabetes Care India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ascensia Diabetes Care India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
